Functional Connectivity Analysis in Neurodegenerative Diseases

Functional connectivity analysis involves quantifying statistical dependencies among spatially distinct brain regions, typically using resting-state functional magnetic resonance imaging to map intrinsic networks. In neurodegenerative diseases, progressive synaptic loss, protein aggregation and cellular atrophy disrupt these networks, leading to characteristic patterns of disconnection that correlate with clinical symptoms. Studies have revealed that early alterations in connectivity often precede overt atrophy, offering a window for preclinical detection and longitudinal tracking. Graph theoretical approaches have elucidated changes in network topology—such as reduced global efficiency, altered clustering and breakdown of small-world architecture—in conditions including Alzheimer’s disease, frontotemporal dementia and Parkinson’s disease. Moreover, multimodal imaging combining functional connectivity with molecular markers such as tau-PET or synaptic density tracers has begun to clarify how protein pathology propagates along connected pathways. These advances underpin the pursuit of functional network metrics as biomarkers for diagnosis, prognostication and monitoring therapeutic effects, with potential applications ranging from patient stratification in clinical trials to personalised interventions aimed at network preservation or restoration.

Research from Nature Portfolio

Recent studies have demonstrated that in tauopathies such as Alzheimer’s disease, higher baseline functional connectivity predicts regions of future tau accumulation, supporting a transneuronal propagation model of pathology. Resting-state fMRI combined with longitudinal tau-PET revealed that tightly connected nodes exhibit correlated increases in tau burden, and network measures can forecast subsequent spread beyond atrophic regions. In syndromes linked to frontotemporal lobar degeneration, multimodal imaging integrating synaptic density PET, diffusion MRI and functional connectivity has shown that reduced synaptic markers are associated with widespread network disruption, and that connectivity strength moderates the relationship between synaptic loss and clinical severity. These findings highlight the interplay between molecular pathology and network architecture in driving symptom onset and progression.

Functional Connectivity Analysis in Neurodegenerative Diseases publication trend

The graph below shows the total number of articles in functional connectivity analysis in neurodegenerative diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Functional connectivity: Statistical correlation or synchronisation between neural signals in distinct brain regions, often measured via resting-state fMRI.

Resting-state fMRI: A functional imaging technique capturing spontaneous blood-oxygen-level-dependent fluctuations when the subject is not performing a task.

Small-world architecture: A network topology characterised by high local clustering and short path lengths, balancing segregation and integration of information.

Clustering coefficient: A graph metric quantifying the degree to which nodes tend to cluster together, reflecting local connectivity.

Global efficiency: A measure of network integration, defined as the inverse of the average shortest path length among all pairs of nodes.

Tau-PET: Positron emission tomography imaging using radioligands that bind to tau proteins, enabling in vivo mapping of tau pathology.

Synaptic density PET: Molecular imaging of synaptic vesicle proteins, providing an index of synaptic integrity across brain regions.

References

1. Synaptic density affects clinical severity via network dysfunction in syndromes associated with frontotemporal lobar degeneration. Nature Communications (2023).
2. Exploring the link between brain topological resilience and cognitive performance in the context of aging and vascular risk factors: A cross-ethnicity population-based study. Science Bulletin (2024).
3. Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease. Nature Communications (2020).
4. Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?. NeuroImage Clinical (2018).
5. Network Analysis of Intrinsic Functional Brain Connectivity in Alzheimer's Disease. PLOS Computational Biology (2008).
6. Disrupted Small-World Brain Networks in Moderate Alzheimer's Disease: A Resting-State fMRI Study. PLOS ONE (2012).
7. Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends in Neurosciences (2013).